Summary
applying Belfand where there had been no sovereign immunity defense in the answer
Summary of this case from Milord-Francois v. The N.Y. State Office of the Medicaid Inspector Gen.Opinion
14515 Index No. 154419/19 Case No. 2021-00847
11-18-2021
Ruprecht, Hart, Ricciardulli & Sherman, LLP, New York (Jessica M. Anderson of counsel), for appellant. Monaco & Monaco, LLP, Brooklyn (Frank A. Delle Donne of counsel), for respondent.
Ruprecht, Hart, Ricciardulli & Sherman, LLP, New York (Jessica M. Anderson of counsel), for appellant.
Monaco & Monaco, LLP, Brooklyn (Frank A. Delle Donne of counsel), for respondent.
Renwick, J.P., Gonza´lez, Kennedy, Scarpulla, Rodriguez, JJ.
Order, Supreme Court, New York County (Paul A. Goetz, J.), entered December 9, 2020, which denied defendant New Jersey Transit Corp.'s motion to dismiss the complaint as against it under the doctrine of sovereign immunity, unanimously affirmed, without costs.
We adhere to our prior holdings in Fetahu v. New Jersey Transit Corp., 197 A.D.3d 1065, 154 N.Y.S.3d 50 (1st Dept. 2021) ; Belfand v. Petosa, 196 A.D.3d 60, 148 N.Y.S.3d 457 (1st Dept. 2021) ; and Henry v. New Jersey Tr. Corp., 195 A.D.3d 444, 144 N.Y.S.3d 851 (1st Dept. 2021), and conclude that, here too, New Jersey Transit (NJT) waived its sovereign immunity defense.
The motion court should not have concluded, however, that New Jersey Transit consented to suit in sister courts by way of the New Jersey Tort Claims Act (see Belfand, 196 A.D.3d at 69, 148 N.Y.S.3d 457 ).
On April 30, 2019, plaintiff filed a verified complaint alleging that she was injured on May 13, 2018 when she tripped on the gap between the train and station platform at Pennsylvania Station while exiting a NJT train because of, inter alia, NJT's negligence.
On June 24, 2019, NJT and defendant Amtrak submitted a combined answer that contained 36 affirmative defenses, and cross claims for contribution and indemnification, but no sovereign immunity defense. On July 10, 2020, NJT submitted a motion seeking dismissal based on sovereign immunity.
We find that NJT's conduct during its nearly 15–month delay in moving for dismissal on sovereign immunity grounds was sufficient to constitute waiver (cf. Belfand, 196 A.D.3d at 72, 148 N.Y.S.3d 457 ). During this period, NJT requested an extension of its time to answer, which was granted on consent. In June 2019, NJT served with its answer a combined notice for discovery, inspection and deposition. In May 2020, plaintiff responded by serving her bill of particulars, complying with NJT's discovery demands, and executing numerous HIPAA authorizations. NJT also participated in a June 15, 2020 compliance conference where it consented to a case scheduling order directing depositions, without raising a defense of sovereign immunity. NJT's cross claims against its codefendants for contribution and indemnification evinced its intent to fully litigate in New York courts this matter on its merits.
As in Belfand , plaintiff's claim is now time-barred in New Jersey through no fault of her own (see Belfand, 196 A.D.3d at 73, 148 N.Y.S.3d 457 ). Since plaintiff alleged that she was injured on May 13, 2018, the statute of limitations expired under New Jersey law on May 13, 2020 ( NJ Stat Ann § 59:8–8 [b]). NJT did not move for dismissal on sovereign immunity grounds until nearly two months after the statute of limitations had run. NJT now seeks to pivot on the Supreme Court's decision in Franchise Tax Bd. of California v. Hyatt, ––– U.S. ––––, 139 S. Ct. 1485, 203 L.Ed.2d 768 (2019), which was issued on May 13, 2019, more than one month before NJT answered the complaint. We have previously noted the vintage of the sovereign immunity defense and rejected the argument that NJT could not have raised a sovereign immunity defense before Hyatt was decided (see Fetahu, 197 A.D.3d at 1065–1066, 154 N.Y.S.3d 50 ; Belfand, 196 A.D.3d at 72–73, 148 N.Y.S.3d 457 ). Here, Hyatt and its reasoning were available to NJT at the time of its answer. Under the totality of these circumstances, NJT's litigation conduct in this action should be deemed an "affirmative invocation of our courts' jurisdiction" that effected a waiver of its sovereign immunity ( Belfand, 196 A.D.3d at 73, 148 N.Y.S.3d 457 ; accord Henry, 195 A.D.3d at 445, 144 N.Y.S.3d 851 ).